Yttrium 90 microspheres for the treatment of hepatocellular carcinoma

Keyphrases

• Yttrium-90 Microspheres 100%
• Hepatocellular Carcinoma 100%
• Tumor 66%
• Patient Selection 66%
• Liver Parenchyma 66%
• Tumor Invasion 33%
• Transplantable 33%
• Liver Transplantation 33%
• Fibrosis 33%
• Radioembolization 33%
• Vascular Injury 33%
• Technical Aspects 33%
• Dosimetry 33%
• Unresectable Hepatocellular Carcinoma 33%
• Blood Supply 33%
• Nausea 33%
• Advanced Stage 33%
• Normal Liver 33%
• Clinical Aspects 33%
• Micron-sized 33%
• Yttrium-90 Radioembolization 33%
• Transarterial 33%
• TheraSphere 33%
• Resection 33%
• Radioisotopes 33%
• Large Tumors 33%
• Abdominal Pain 33%
• External Radiation 33%
• Hepatic Dysfunction 33%
• Portal Vein Thrombosis 33%
• Highly Concentrated 33%
• Palliative Therapy 33%
• Portal Venous Blood 33%
• Biliary Injury 33%
• Downstaging 33%
• GI Ulcers 33%
• Radiation Pneumonitis 33%
• Treatment Verification 33%
• SIR-Spheres 33%
• Incidence of Complication 33%
• Radioactive Particles 33%
• Embolic Particles 33%
• Concentrated Radiation 33%
• Glass Based 33%
• Resin-based 33%

Medicine and Dentistry

• Hepatocellular Carcinoma 100%
• Yttrium 90 100%
• Microsphere 100%
• Neoplasm 50%
• Patient Selection 33%
• Radioembolization 33%
• Liver Parenchyma 33%
• Symptomatic Treatment 16%
• Outpatient 16%
• Nausea 16%
• Radioisotope 16%
• Clinical Feature 16%
• Tumor Invasion 16%
• Abdominal Pain 16%
• Fibrosis 16%
• Phlebothrombosis 16%
• Venous Blood 16%
• Blood Vessel Injury 16%
• Dosimetry 16%
• Vascularity 16%
• Liver Dysfunction 16%
• Radiation Pneumonia 16%
• Biliary Injury 16%
• Liver Transplantation 16%
• Ulcer 16%
• Single Isomorphous Replacement 16%